From GlobeNewswire: 2025-04-28 10:41:00

BioPorto A/S will host a webcast for investors on the results of the first quarter of 2025. The CFO will present the results on May 8th at 13:00. Registration is open, and participants can submit questions in advance. BioPorto focuses on early identification and assessment of acute kidney injury. Their leading product, based on the NGAL biomarker, aids in early identification of acute kidney injury. The company’s shares are listed on NASDAQ Copenhagen. For more information, visit www.bioporto.com.



Read more at GlobeNewswire: BioPorto A/S afholder webcast for investorer om resultatet